Nicola Maurea

The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin

Vincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea et al. · Cardiovascular Diabetology · 2021 · 364 citations · Full text

Medicine, Cardiology, Pharmacology +17

Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer

Luigi Tarantini, Giovanni Cioffi, Stefania Gori et al. · Journal of Cardiac Failure · 2011 · 115 citations

Medicine, Oncology, Pharmacology +16

Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience

Immacolata Capasso, Emanuela Esposito, Francesca Pentimalli et al. · Cancer Biology & Therapy · 2010 · 107 citations · Full text

Medicine, Endocrinology, Oncology +15

Ranolazine Protects from Doxorubicin-Induced Oxidative Stress and Cardiac Dysfunction

Carlo G. Tocchetti, Andrea Carpi, Carmela Coppola et al. · European Journal of Heart Failure · 2014 · 90 citations · Full text

Medicine, Cardiology, Pharmacology +16

Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity

Vincenzo Quagliariello, Raffaele Vecchione, Carmela Coppola et al. · Nutrients · 2018 · 89 citations · Full text

Pharmacy, Pharmacology, Toxicology +17